Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Phthiobuzonum/diclothane compound topical formulation

A topical preparation technology, applied to the compound topical preparation of phthalidene/dyclonine and its preparation, in the field of treating herpes simplex and herpes zoster skin diseases, so as to improve the quality of life, prevent infection, and improve clinical compliance sexual effect

Active Publication Date: 2011-01-05
BEIJING HUMANWELL JUNWEI PHARM TECH CO LTD
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there is no report on the combination of phthalide and dyclonine and its use in the treatment of viral skin diseases such as herpes zoster

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Phthiobuzonum/diclothane compound topical formulation
  • Phthiobuzonum/diclothane compound topical formulation
  • Phthiobuzonum/diclothane compound topical formulation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

Embodiment 2

Embodiment 3

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a compound topical preparation of fitbamzone dyclonine used for curing viral skin diseases, such as herpes zoster, etc. The topical preparation of fitbamzone dyclonine complex prescription consists of following components by percentage composition: (1) 0.1 to 10 weight percent of the fitbamzone, (2) 0.1 to 10 weight percent of the dyclonine, and (3) pharmaceutically acceptable excipient. The compound topical preparation used for curing the herpes zoster can stop pain, immediately relieve the suffering of a patient to the maximum, improve the life quality of the patientand contribute to improve the clinical compliance of the patient based on ensuring the curative effect of anti-virus and achieving the purpose of treatment. The compound topical preparation has the advantages of having an evident curative effect on the herpes zoster, a good analgesic effect, stable preparation performance, controllable quality, a good curative effect, and nonirritant to skin without causing allergic reaction.

Description

A compound topical preparation of phthalobutane / dyclonine technical field The invention relates to topical pharmaceutical preparations, more specifically, a compound topical preparation of phthalobutane / dyclonine and a preparation method thereof, which are used for treating herpes simplex and herpes zoster skin diseases. Background technique Virus infection has always been a serious social topic that people care about. Virus infection causes multiple diseases and seriously threatens people's health. Viral skin diseases occupy an important position in skin diseases, and herpes zoster (Herpes Zoster) is caused by varicella zoster. The acute inflammatory skin disease caused by herpes zoster virus is called "waist-wrapped fire dragon" and "waist-wrapped fire pill" in traditional Chinese medicine, commonly known as "spider sore". Its main features are clusters of blisters distributed in clusters along one side of the peripheral nerve, accompanied by obvious neuralgia. The firs...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/107A61P17/00A61K9/06A61K31/472A61P31/12A61K9/00A61K31/435
Inventor 高永良李志红王晋李劲彤
Owner BEIJING HUMANWELL JUNWEI PHARM TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products